Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Seibyl

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 15, 2009
Dopamine and serotonin transporter availability during acute alcohol withdrawal: effects of comorbid tobacco smokingKelly P Cosgrove, Erica Krantzler, Erin B Frohlich, et al.
Drug and Alcohol Dependence|January 16, 2010
SPECT imaging of nicotinic acetylcholine receptors in nonsmoking heavy alcohol drinking individualsIrina Esterlis, Kelly P Cosgrove, Ismene L Petrakis, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2006
Development of SPECT imaging agents for the norepinephrine transporters: [123I]INERGilles D Tamagnan, Eric Brenner, David Alagille, et al.
Neuroimage|September 2, 2003
Selective frontal, parietal, and temporal networks in generalized seizuresHal Blumenfeld, Michael Westerveld, Robert B Ostroff, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2010
Pharmacokinetic modeling and [¹²³]5-IA-85380 single photon emission computed tomography imaging in baboons: optimization of dosing regimen for ABT-089Chih-Liang Chin, Robert A Carr, Daniel A Llano, et al.
Psychopharmacology|July 11, 2002
Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptomsWalid Abi-Saab, John P Seibyl, D Cyril D'Souza, et al.
Psychopharmacology|February 1, 2005
Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamineHyun-Sang Cho, Deepak C D'Souza, Ralitza Gueorguieva, et al.
JAMA Neurology|October 17, 2014
The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington diseaseDavid S Russell, Olivier Barret, Danna L Jennings, et al.
Synapse (New York, N.Y.)|July 31, 2009
GABAA-benzodiazepine receptor availability in smokers and nonsmokers: relationship to subsyndromal anxiety and depressionIrina Esterlis, Kelly P Cosgrove, Jeffery C Batis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 13, 2019
Tau PET imaging with <sup>18</sup>F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans StudyAndre Mueller, Santiago Bullich, Olivier Barret, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 15, 2009
Dopamine and serotonin transporter availability during acute alcohol withdrawal: effects of comorbid tobacco smokingKelly P Cosgrove, Erica Krantzler, Erin B Frohlich, et al.
Drug and Alcohol Dependence|January 16, 2010
SPECT imaging of nicotinic acetylcholine receptors in nonsmoking heavy alcohol drinking individualsIrina Esterlis, Kelly P Cosgrove, Ismene L Petrakis, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2006
Development of SPECT imaging agents for the norepinephrine transporters: [123I]INERGilles D Tamagnan, Eric Brenner, David Alagille, et al.
Neuroimage|September 2, 2003
Selective frontal, parietal, and temporal networks in generalized seizuresHal Blumenfeld, Michael Westerveld, Robert B Ostroff, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2010
Pharmacokinetic modeling and [¹²³]5-IA-85380 single photon emission computed tomography imaging in baboons: optimization of dosing regimen for ABT-089Chih-Liang Chin, Robert A Carr, Daniel A Llano, et al.
Psychopharmacology|July 11, 2002
Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptomsWalid Abi-Saab, John P Seibyl, D Cyril D'Souza, et al.
Psychopharmacology|February 1, 2005
Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamineHyun-Sang Cho, Deepak C D'Souza, Ralitza Gueorguieva, et al.
JAMA Neurology|October 17, 2014
The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington diseaseDavid S Russell, Olivier Barret, Danna L Jennings, et al.
Synapse (New York, N.Y.)|July 31, 2009
GABAA-benzodiazepine receptor availability in smokers and nonsmokers: relationship to subsyndromal anxiety and depressionIrina Esterlis, Kelly P Cosgrove, Jeffery C Batis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 13, 2019
Tau PET imaging with <sup>18</sup>F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans StudyAndre Mueller, Santiago Bullich, Olivier Barret, et al.
Pageof 10